Market Research Report
Sleep Aids in Germany
|Published by||Euromonitor International||Product code||980990|
|Published||Content info||26 Pages
Delivery time: 1-2 business days
|Sleep Aids in Germany|
|Published: December 21, 2020||Content info: 26 Pages||
Contact bans, movement restrictions, school closures, reduced social interaction and financial woes as a result of the pandemic have all resulted in heightened stress levels, having a negative impact on the physical and mental health of many German consumers in 2020. As consumers sought ways to alleviate stress and address resulting sleep problems, demand for products targeted to resolve these issues therefore rose in 2020, including sleep aids. There is industry consensus that 2020's increase i...
Euromonitor International's Sleep Aids in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
List OF CONTENTS AND TABLES
KEY DATA FINDINGS
Increasing anxiety as a result of pandemic exacerbates nation's sleep problems
The enduring appeal of herbal/traditional products
GlaxoSmithKline retains overall lead due to natural positioning of its brand Baldriparan
RECOVERY AND OPPORTUNITIES
Positive outlook as mental health and sleep problems gain greater acknowledgement
''Please show me your ID'' - mandatory prescription for people 65+?
E-commerce continues to record strong performance but prospects not as strong compared to distribution of OTC products
COVID-19 impact on consumer health
COVID-19 country impact
What next for consumer health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
GLOBAL MACROECONOMIC ENVIRONMENT
GLOBAL INDUSTRY ENVIRONMENT